Skip to content

cost-utility of analysis of different stroke rehabilitation model

cost-utility of analysis of different stroke rehabilitation model

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006247
Enrollment
Unknown
Registered
2015-04-08
Start date
2015-04-13
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

ESUS group:The ESUS consists of a mobile team that coordinates early supported discharge and further rehabilitation. Mobile team complete the system evaluation and making treatment plan within a week
OSUS group:Doctor issues stroke rehabilitation brochures to patients. Patients receives the traditional treatment of stroke unit without giving standardized community-based rehabilitation therapy.

Sponsors

Department of Xiangyang Hospital, Hubei University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Hospitalize patients first diagnosed as stroke according to the fourth National Conference on cerebrovascular disease, in 1996. Focus confirmed by head CT or MRI. Male or female, 45 to 75 years of age; SSS score 2-57; Onset of symptoms to admission less than 7 days; Admission to join the study less than 72 hours; Sign informed consent and do not participate other studies.

Exclusion criteria

Exclusion criteria: Brain hemorrhage or Sub-arachnoid haemorrhage caused by cerebral trauma; Combined with severe primary disease of heart, liver, kidney and hematological system; With cognitive disorder, history of psychosis, history of dementia, substance abuse, history of alcoholism; With metal implant such as cardiac pacemaker, metal stent, steel plate; With gestation or lactation period or fertility plan; Combined with malignant tumor or severe progressive disease in other system; Have been recruited by other clinical trial in recent 3 months; Unable to complete the basic course of treatment; With poor treatment re adherence or unable to follow-up; Other conditions that unable to continue the trial confirmed by assessors.

Design outcomes

Secondary

MeasureTime frame
Scandinavian Stroke Scale;Modified Rankin Scale;

Primary

MeasureTime frame
Cost;EQ-5D;Quality-adjusted life years;

Countries

China

Contacts

Public ContactJing Tian
15030662@qq.com+86 15172586364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026